MedTrace Logo

Study of Hepatitis C Virus (HCV) Viral Kinetics in HIV/HCV and HCV Patients

NCT00703560 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 72

Last updated 2013-01-21

No results posted yet for this study

Summary

The purpose of this study is to evaluate what happens to hepatitis C virus in response to treatment with pegylated interferon and ribavirin in patients with HCV compared to those with HIV and HCV.

This research is being done to help us identify how the composition of HCV changes with interferon in different populations. We will examine how quickly HCV is cleared from your body and what factors may influence that clearance. This information may help us find better treatments for HCV.

Conditions

  • Hepatitis C

Sponsors & Collaborators

  • University of Texas Southwestern Medical Center

    lead OTHER

Principal Investigators

  • Mamta K. Jain, MD, MPH · UT Southwestern Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2011-09-30
Completion
2013-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00703560 on ClinicalTrials.gov